Chemical stability of esomeprazole in biorelevant bicarbonate buffer and an exploratory study for specific degradation products

This study aimed to evaluate the impact of biorelevant bicarbonate buffer solutions (BCB) on drug degradation relative to phosphate buffer solutions (PPB). Esomeprazole (ESM) was selected as a model compound. Stability studies were conducted at 37 °C using 10 mM BCB and 31 mM PPB (both at pH 5.5; buffer capacity (β) = 4.0 mM/pH; ionic strength (I) = 0.14 M). Degradation products were quantified at 4 time points by HPLC. No significant difference was observed in the degradation rate constant of ESM between BCB and PPB. However, LC-MS analysis revealed a distinct tendency that two degradation products with m/z values of 330 and 298 were more abundant in BCB than in PPB. The putative structures of these degradation products matched the previously reported compounds. These findings suggest that buffer species can influence degradation pathways even under equivalent β and I. Consequently, the use of biorelevant buffer systems is essential for accurate assessments of degradation products.

Authors

Institutions

Publication Details

Journal
Journal of Pharmaceutical and Biomedical Analysis
Published
2025-12-05
DOI
https://doi.org/10.1016/j.jpba.2025.117305
Primary Topic
Analytical Methods in Pharmaceuticals
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chemical stability of esomeprazole in biorelevant bicarbonate buffer and an exploratory study for specific degradation products

Kiyohiko Sugano, Kōichi Inoue, Takahiro Takayama, Ayaka Takasusuki
Journal of Pharmaceutical and Biomedical Analysis
Analytical Methods in Pharmaceuticals
article

Chemical stability of esomeprazole in biorelevant bicarbonate buffer and an exploratory study for specific degradation products

Kiyohiko Sugano, Kōichi Inoue, Takahiro Takayama, Ayaka Takasusuki
article en

Abstract

This study aimed to evaluate the impact of biorelevant bicarbonate buffer solutions (BCB) on drug degradation relative to phosphate buffer solutions (PPB). Esomeprazole (ESM) was selected as a model compound. Stability studies were conducted at 37 °C using 10 mM BCB and 31 mM PPB (both at pH 5.5; buffer capacity (β) = 4.0 mM/pH; ionic strength (I) = 0.14 M). Degradation products were quantified at 4 time points by HPLC. No significant difference was observed in the degradation rate constant of ESM between BCB and PPB. However, LC-MS analysis revealed a distinct tendency that two degradation products with m/z values of 330 and 298 were more abundant in BCB than in PPB. The putative structures of these degradation products matched the previously reported compounds. These findings suggest that buffer species can influence degradation pathways even under equivalent β and I. Consequently, the use of biorelevant buffer systems is essential for accurate assessments of degradation products.

Journal of Pharmaceutical and Biomedical AnalysisVol. 270
Ritsumeikan University (JP)
Openalex Percentile: Top 59%
Analytical Methods in Pharmaceuticals
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.